In pancreatic ductal adenocarcinoma (PDAC), the metabolism of Ala, Pro, Gln, Asp and Ser, as well as BCAT2-mediated branched-chain amino acid (BCAA), has been usurped for malignant progression [3–11]. This evidence concerns the gene BCAT2 and pancreatic ductal adenocarcinoma.